Pascal Claudepierre

6.9k citations
187 papers · 3.2k · 1 hit paper · h-index 31

Impact in

  • Rheumatology top 0.1%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 5%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Spondyloarthritis Studies and Treatments 138
    • Rheumatoid Arthritis Research and Therapies 59
    • Osteoarthritis Treatment and Mechanisms 4
    • Psoriasis: Treatment and Pathogenesis 34

Pascal Claudepierre

165 papers receiving 3.1k citations

Pascal Claudepierre's Hit Papers

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database 2022 · 111 citations
1110+1+2Years since publication255075100

Peers

Pascal Claudepierre
Comparison fields: 5 of 103
  • Rheumatology 2.4k
  • Immunology 742
  • Hematology 376
  • Orthopedics and Sports Medicine 227
  • Complementary and Manual Therapy 31
Replace Cédric Lukas with:
Cédric Lukas France
R. B. M. Landewé Netherlands
Irene E. van der Horst‐Bruinsma Netherlands
Angela Padula Italy
S. E. Gabriel United States
Adeline Ruyssen‐Witrand France
Wayne Tsuji United States
Hildrun Haibel Germany
Pierluigi Macchioni Italy
Rubén Queiró Spain
Pascal Claudepierre relative to Cédric Lukas France Cédric Lukas's profile →
Citations per field
00.5×1.5×1.8×
Cédric Lukas · 1×
Citations per year

Countries citing papers authored by Pascal Claudepierre

Since Specialization
Citations

This map shows the geographic impact of Pascal Claudepierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Claudepierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Claudepierre more than expected).

Fields of papers citing papers by Pascal Claudepierre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Claudepierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Claudepierre. The network helps show where Pascal Claudepierre may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Claudepierre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Claudepierre Line = papers co-authored together Pascal Claudepierre links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2009174
2 2009171
3 2013124
4 2014124
5
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Hit paper breakdown →
2022111
6
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C.
2004110
7 200095
8 201194
9
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
200790
10 201783
11 200767
12 201464
13
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
200563
14 201660
15 200456
16 201853
17 201453
18 201449
19 201646
20
Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy.
199743

About Pascal Claudepierre

Pascal Claudepierre is a scholar working on Rheumatology, Immunology, Orthopedics and Sports Medicine, Hematology and Surgery, having authored 187 papers that have together received 3.2k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (138 papers), Rheumatoid Arthritis Research and Therapies (59 papers), Psoriasis: Treatment and Pathogenesis (34 papers), Bone and Joint Diseases (19 papers), Autoimmune and Inflammatory Disorders Research (9 papers), Therapeutic Uses of Natural Elements (7 papers), Spine and Intervertebral Disc Pathology (7 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). The work is most often cited by research in Rheumatology (2.4k citations), Immunology (742 citations), Hematology (376 citations), Orthopedics and Sports Medicine (227 citations) and Complementary and Manual Therapy (31 citations). Pascal Claudepierre has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Maxime Dougados, Daniel Wendling, Xavier Chevalier, Désirée van der Heijde, Alain Saraux, Anna Moltó, M. Reijnierse, É. Sbidian, A. Feydy and Martín Rudwaleit. Their work appears in journals such as Annals of the Rheumatic Diseases, RMD Open, Lara D. Veeken, Arthritis Care & Research and The Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact